Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CLARIVATE PLC (CLVT)

Clarivate Q3 net loss widens to $80.8M on $62.2M impairment; adjusted EPS rises to $0.21

Mixed Impact 4 of 5 earnings Written later

Clarivate reported third-quarter 2026 results, with continuing-operations revenue down 9.2% to $481.6 million, mainly from inorganic disposals, and organic revenue up 0.4%. The company completed the sale of its Life Sciences & Healthcare segment on October 6, 2026, for net cash proceeds of $488.4 million, and updated its full-year 2026 outlook excluding that segment, so shareholders will see a smaller revenue base and a reported net loss driven by a non-cash impairment.

Key points

  • Q3 net loss including discontinued operations was $80.8 million, or $0.13 per diluted share, versus a net loss of $28.3 million, or $0.04, a year earlier, driven by a $62.2 million non-cash goodwill impairment
  • Adjusted diluted EPS was $0.21 versus $0.18 a year earlier; Adjusted EBITDA including discontinued operations was $245.3 million versus $252.4 million
  • Full-year 2026 outlook (continuing operations): revenue $1.965 billion to $1.985 billion, adjusted diluted EPS $0.73 to $0.77, free cash flow $320 million to $340 million

The filing

CompanyCLARIVATE PLC (CLVT)
Form8-K, current report
Filed with the SECNov 3, 2026, 8:04 AM ET
Accession number0001764046-26-000125

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.